San Francisco Bay Area biotech stories.
Wednesday, August 8, 2012
CardioDx heart disease test wins Medicare coverage
A key national Medicare contractor will cover the cost of a coronary artery disease test developed by CardioDx Inc.
The decision disclosed Tuesday by Palmetto GBA, a national contractor that administers Medicare benefits in Columbia, S.C., means that Medicare will cover the test for as many as 40 million enrollees. Coverage is retroactive to Jan. 1.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)